Please assess the completion status of the following clinical trial:

Trial Title: Ivabradine to Improve Endothelial Function in Patients With Coronary Artery Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* history of stable coronary disease~* complete coronary revascularization with PCI at least 1 month prior to recruitment~* sinus rhythm~* absence of anginal symptoms~Exclusion Criteria:~* resting heart rate \<60 beats per minute~* severe reduction of left ventricle ejection fraction (\<40%)~* coronary artery by-pass surgery~* myocardial infarction, stroke or cerebral transient ischemic attack within the previous 6 months~* implanted pacemaker, cardioverter, or defibrillator~* sick sinus syndrome~* sinoatrial block~* congenital long QT~* complete atrioventricular block

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Ivabradine group (Type: ACTIVE_COMPARATOR): Ivabradine 5 mg twice daily + standard medical therapy
- Control group (Type: OTHER): Standard medical therapy

Based on this trial design, predict the completion outcome and termination type (if applicable).